Today, the North Carolina General Assembly completed its short session and left Raleigh with the matter of Medicaid expansion unresolved, meaning that 600,000 hard-working, would-be eligible North Carolinians are forced to wait even longer for a chance at affordable access to care.
The House Appropriations Committee will vote today to approve its FY 2023 spending bill including a $2.5 billion funding increase for the National Institutes of Health (NIH), a $466 million funding boost for the National Cancer Institute (NCI) and $2.75 billion for the Advanced Research Projects Agency on Health (ARPA-H).
As a nonprofit entity whose mission is improving the lives of people with cancer and their families, the American Cancer Society isn’t taking sides on the decision. However, the decision will impact cancer patients and their families and is likely to disproportionately effect communities of color.
The nation’s leading organizations from across the health care spectrum are calling on Congress to extend the expanded Affordable Care Act (ACA) health care premium tax credits.
Today the Biden Administration announced its intention for the U.S. Food and Drug Administration (FDA) to put forth a proposed rule to set a maximum level of nicotine in cigarettes and certain tobacco products to an amount that would reduce addiction.
Dr. Karen E. Knudsen, the Chief Executive Officer of the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN), will testify before the House Appropriations Subcommittee on Labor, Health, and Human Services and Education, and related agencies today in support of increased federal funding for the National Institutes of Health (NIH), National Cancer Institute (NCI) and the Centers for the Disease Control and Prevention (CDC).
In yet another delay that leaves America’s kids at risk, the FDA has told a federal court that it won’t finish its review of marketing applications for the most popular e-cigarette products until June 2023 – nearly two years after the September 9, 2021, court-ordered deadline to do so.
Washington, D.C. – Today U.S.
Eighty-seven organizations representing patients with chronic and acute health conditions, sent a letter to Congress today urging them to improve the diversity of enrollment in clinical trials as part of this year’s Prescription Drug User Fee Act (PDUFA) reauthorization.
Washington, D.C.--Today ACS CAN filed comments with the Centers for Disease Control and Prevention regarding proposed clinical practice guidelines for prescribing opioids.